Ventricular Assist Device Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00$ 8,900.00

Ventricular Assist Device Market: By Product (Left Ventricular Assist Device, Right Ventricular Assist Device, Bi-Ventricular Assist Device, Total Artificial Heart) By Type (Pulsatile Flow, Continuous Flow), By Design (Implantable Ventricular Assist Device, Transcutaneous Ventricular Assist Device) by Application (Bridge to Transplant, Destination Therapy, Others) Geography

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Categories: ,

Report

Description

Ventricular Assist Device Market size is valued at USD 1,950.0 million in 2021 and is expected to reach a value of USD 3,407.5 million by 2028, growing at a CAGR of 8.3% during the forecast period 2022 to 2028. The global market provides a detailed overview of the ventricular assist device market and that can be segmented by product, type of flow, design, and application. By product, the ventricular assist device market has been segmented into left ventricular assist device, right ventricular assist device, bi-ventricular assist device, and the total artificial heart. The left ventricular assist device segment is likely to be the largest and fastest-growing segment in terms of product. Based on the type of flow, the ventricular assist device market is segmented into pulsatile flow and continuous flow. Among these, the pulsatile flow segment is expected to have the fastest-growing market during the forecast period 2022-2028. On the basis of design, the market is segregated into implantable ventricular assist devices and transcutaneous ventricular assist devices. The implantable ventricular assist device held a considerable market share during the forecast period. Based on application, the market is segregated into a bridge to transplant, destination therapy, and others. Bridge to transplant segment held considerable market share during the estimated period.

Key Developments:

In May 2021, The Ministry of Health, Labor, and Welfare (MHLW) of Japan has approved the Impella CP heart pump. The availability of Impella hemodynamic support to patients with heart failure will be facilitated by this approval, hastening the company’s growth.

Ventricular Assist Device Market

MARKET SUMMARY
-
8.3%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 8.3%
  • Largest Market– North American
  • Fastest Growing Market– Asia-Pacific

Ventricular Assist Device Market

  • The ventricular assist device market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The ventricular assist device market is segmented based on product, type, design, application and geography.
Key Players
  • Abbott (US)
  • Reliant Heart Inc. (US)
  • Abiomed Inc. (US)
  • Cardiac Assist Inc. (US)
  • Cirtec (US)
Ventricular Assist Device Market Drivers

The pursuit of unhealthy lifestyles, rapid globalization, the aging population and the rising demand for heart transplants, the lack of organ donors and the rapid advancement of technology, as well as the demand for ventricular assist devices, all contribute to the rising incidence of chronic diseases and hence increases the demand for the market.


Asia Pacific Got Significant Share

Ventricular Assist Device Market

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The ventricular assist device market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The ventricular assist device market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The ventricular assist device market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The ventricular assist device market report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The ventricular assist device market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
ventricular assist device market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The ventricular assist device market is projected to expand at a CAGR of 6.3% during the forecast period

The major players in the global ventricular assist device market are Abbott (US), Reliant Heart Inc. (US), Abiomed Inc. (US), Cardiac Assist Inc. (US), Cirtec (US), CorWave SA (France), Medtronic plc (Ireland), Fineheart (France) and Berlin Heart GmbH (Germany).

Asia Pacific is the fastest-growing region for ventricular assist device market


Report

Table Of Content

1. Executive Summary
2. Global Ventricular Assist Device Market Introduction
2.1. Global Ventricular Assist Device Market – Taxonomy
2.2. Global Ventricular Assist Device Market –Definitions
2.2.1. By Product
2.2.2. By Type of Flow
2.2.3. By Design
2.2.4. By Application
2.2.5. By Region
3. Global Ventricular Assist Device Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Ventricular Assist Device Market Dynamic Factors – Impact Analysis
3.6. Global Ventricular Assist Device Market – Competition Landscape
4. Global Ventricular Assist Device Market Analysis,2017-2021 and Forecast, 2022-2028
4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Ventricular Assist Device Market, By Product, 2017-2021 and Forecast, 2022-2028(Revenue, USD Mn)
5.1. Left Ventricular Assist Device
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Right Ventricular Assist Device
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Bi-Ventricular Assist Device
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Total Artificial Heart
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
6. Global Ventricular Assist Device Market, By Type of Flow, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Pulsatile Flow
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Continuous Flow
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
7. Global Ventricular Assist Device Market, By Design, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Implantable Ventricular Assist Device
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Transcutaneous Ventricular Assist Device
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
8. Global Ventricular Assist Device Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Bridge to Transplant
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Destination Therapy
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others)
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Ventricular Assist Device Market Forecast, By Region, 2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Ventricular Assist Device Market – Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Region, 2022-2028
10. North America Ventricular Assist Device Market Analysis,2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
10.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Left Ventricular Assist Device
10.1.2. Right Ventricular Assist Device
10.1.3. Bi-Ventricular Assist Device
10.1.4. Total Artificial Heart
10.2. Type of Flow Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Pulsatile Flow
10.2.2. Continuous Flow
10.3. Design Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Implantable Ventricular Assist Device
10.3.2. Transcutaneous Ventricular Assist Device
10.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Bridge to Transplant
10.4.2. Destination Therapy
10.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others)
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Ventricular Assist Device Market – Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country, 2022-2028
10.7. North America Ventricular Assist Device Market Dynamics – Trends
11. Europe Ventricular Assist Device Market Analysis, 2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
11.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Left Ventricular Assist Device
11.1.2. Right Ventricular Assist Device
11.1.3. Bi-Ventricular Assist Device
11.1.4. Total Artificial Heart
11.2. Type of Flow Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Pulsatile Flow
11.2.2. Continuous Flow
11.3. Design Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Implantable Ventricular Assist Device
11.3.2. Transcutaneous Ventricular Assist Device
11.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Bridge to Transplant
11.4.2. Destination Therapy
11.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others)
11.5. Country Analysis 2017-2021and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Ventricular Assist Device Market – Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country, 2022-2028
11.7. Europe Ventricular Assist Device Market Dynamics – Trends
12. Asia-Pacific Ventricular Assist Device Market Analysis, 2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
12.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Left Ventricular Assist Device
12.1.2. Right Ventricular Assist Device
12.1.3. Bi-Ventricular Assist Device
12.1.4. Total Artificial Heart
12.2. Type of Flow Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Pulsatile Flow
12.2.2. Continuous Flow
12.3. Design Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Implantable Ventricular Assist Device
12.3.2. Transcutaneous Ventricular Assist Device
12.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Bridge to Transplant
12.4.2. Destination Therapy
12.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others)
12.5. Country Analysis2017-2021and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Ventricular Assist Device Market – Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country,2022-2028
12.7. Asia-PacificVentricular Assist Device Market Dynamics – Trends
13. Latin America Ventricular Assist Device Market Analysis,2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
13.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Left Ventricular Assist Device
13.1.2. Right Ventricular Assist Device
13.1.3. Bi-Ventricular Assist Device
13.1.4. Total Artificial Heart
13.2. Type of Flow Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Pulsatile Flow
13.2.2. Continuous Flow
13.3. Design Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Implantable Ventricular Assist Device
13.3.2. Transcutaneous Ventricular Assist Device
13.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Bridge to Transplant
13.4.2. Destination Therapy
13.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others)
13.5. Country Analysis 2017-2021and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Ventricular Assist Device Market – Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country, 2022-2028
13.7. Latin America Ventricular Assist Device Market Dynamics – Trends
14. Middle East and Africa Ventricular Assist Device Market Analysis, 2017-2021and Forecast, 2022-2028(Revenue, USD Mn)
14.1. Product Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Left Ventricular Assist Device
14.1.2. Right Ventricular Assist Device
14.1.3. Bi-Ventricular Assist Device
14.1.4. Total Artificial Heart
14.2. Type of Flow Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Pulsatile Flow
14.2.2. Continuous Flow
14.3. Design Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Implantable Ventricular Assist Device
14.3.2. Transcutaneous Ventricular Assist Device
14.4. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Bridge to Transplant
14.4.2. Destination Therapy
14.4.3. Others (Bridge to Recovery, Bridge to Candidacy, and Others)
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Ventricular Assist Device Market – Opportunity Analysis Index, By Product, Type of Flow, Design, Application, and Country, 2022-2028
14.7. MEA Ventricular Assist Device Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, KeyOfferings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Abbott (US)
15.2.2. Reliant Heart Inc. (US)
15.2.3. Abiomed Inc. (US)
15.2.4. Cardiac Assist Inc. (US)
15.2.5. Cirtec (US)
15.2.6. CorWave SA (France)
15.2.7. Medtronic plc (Ireland)
15.2.8. Fineheart (France)
15.2.9. Berlin Heart GmbH (Germany)
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • Abbott (US)
  • Reliant Heart Inc. (US)
  • Abiomed Inc. (US)
  • Cardiac Assist Inc. (US)
  • Cirtec (US)
  • CorWave SA (France)
  • Medtronic plc (Ireland)
  • Fineheart (France)
  • Berlin Heart GmbH (Germany)

Description

Ventricular Assist Device Market size is valued at USD 1,950.0 million in 2021 and is expected to reach a value of USD 3,407.5 million by 2028, growing at a CAGR of 8.3% during the forecast period 2022 to 2028. The global market provides a detailed overview of the ventricular assist device market and that can be segmented by product, type of flow, design, and application. By product, the ventricular assist device market has been segmented into left ventricular assist device, right ventricular assist device, bi-ventricular assist device, and the total artificial heart. The left ventricular assist device segment is likely to be the largest and fastest-growing segment in terms of product. Based on the type of flow, the ventricular assist device market is segmented into pulsatile flow and continuous flow. Among these, the pulsatile flow segment is expected to have the fastest-growing market during the forecast period 2022-2028. On the basis of design, the market is segregated into implantable ventricular assist devices and transcutaneous ventricular assist devices. The implantable ventricular assist device held a considerable market share during the forecast period. Based on application, the market is segregated into a bridge to transplant, destination therapy, and others. Bridge to transplant segment held considerable market share during the estimated period.

Key Developments:

In May 2021, The Ministry of Health, Labor, and Welfare (MHLW) of Japan has approved the Impella CP heart pump. The availability of Impella hemodynamic support to patients with heart failure will be facilitated by this approval, hastening the company’s growth.

Reviews

There are no reviews yet.

Be the first to review “Ventricular Assist Device Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”

Your email address will not be published. Required fields are marked *

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX